lutein has been researched along with Disease Exacerbation in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 19 (63.33) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drakon, AK; Korchazhkina, NB; Kurguzova, AG; Sheludchenko, VM | 1 |
| Agrón, E; Chew, EY; Cukras, CA; Domalpally, A; Hwang, CK; Keenan, TDL; Wong, WT | 1 |
| García-Montalvo, IA; Matías-Pérez, D | 1 |
| Liu, L; Zhao, N | 1 |
| Evans, JR; Lawrenson, JG | 1 |
| Agrón, E; Chew, EY; Clemons, TE; Danis, RG; Domalpally, A; Ferris, FL; Keenan, TD; Klein, ML; Ratnapriya, R; Rosenfeld, PJ; Sadda, S; Swaroop, A; van Asten, F; Wong, WT | 1 |
| Agrón, E; Chew, EY; Chiu, CY; Clemons, TE; Fan, R; Klein, ML; Ratnapriya, R; Swaroop, A; van Asten, F | 1 |
| Agron, E; Antoszyk, AN; Bernstein, P; Blodi, BA; Bressler, SB; Chandra, SR; Chew, EY; Clemons, TE; Danis, R; Domalpally, A; Elman, MJ; Ferris, FL; Fish, GE; Friberg, TR; Hubbard, GB; Klein, ML; Orth, D; Rosenfeld, PJ; Ruby, AJ; SanGiovanni, JP; Sperduto, R; Toth, CA; Wong, WT | 1 |
| Heimes, B; Lommatzsch, A; Pauleikhoff, D; Spital, G; Zeimer, MB | 1 |
| Agrón, E; Antoszyk, AN; Bernstein, PS; Blodi, BA; Bressler, SB; Chandra, SR; Chew, EY; Clemons, TE; Danis, RP; Domalpally, A; Elman, MJ; Ferris, FL; Fish, GE; Friberg, T; Hubbard, GB; Klein, ML; Orth, D; Rosenfeld, PJ; Ruby, AJ; Sangiovanni, JP; Sperduto, RD; Toth, CA; Wong, WT | 1 |
| Aronow, ME; Chew, EY | 1 |
| Berendschot, TT; Kelly, ER; Kijlstra, A; Lütjohann, D; Plat, J; van der Made, SM | 1 |
| Garhöfer, G; Schmetterer, L; Schmidl, D | 1 |
| Agrón, E; Al-Holou, SN; Chew, EY; Clemons, TE; Cukras, C; Ferris, FL; Tucker, WR | 1 |
| Agrón, E; Al-Holou, SN; Chew, EY; Clemons, TE; Ferris, FL; Sperduto, RD; Tucker, WR | 1 |
| Almansa, I; Arnal, E; Barcia, JM; Bosch-Morell, F; Diaz-Llopis, M; Miranda, M; Muriach, M; Romero, FJ | 1 |
| Fishman, GA; Massof, RW | 1 |
| Ito, T; Metoki, T; Miyagawa, Y; Nakazawa, M; Ohguro, H; Takeuchi, K | 1 |
| Gorin, MB; Mayne, ST; McCarthy, CS; Sternberg, P; Wall, M; Wittes, J | 1 |
| Kontadakis, G; Makridaki, M; Moschandreas, J; Plainis, S; Tsika, C; Tsilimbaris, MK | 1 |
| Anselmetti, G; Bellettato, M; Biban, P; Bonetti, P; Farina, D; Guardione, R; Maestri, A; Mansoldo, C; Manzoni, P; Mostert, M; Priolo, C; Sardei, D | 1 |
| Chew, EY; Clemons, T; Danis, R; Domalpally, A; Ferris, FL; McBee, W; SanGiovanni, JP; Sperduto, R | 1 |
| Frankowski, J; Nyland, J; Pei, K; Pulido, J; Richer, S; Rudy, D; Statkute, L; Stiles, W; Tsipursky, M | 1 |
| Behrens, T; Dasch, B; Fobker, M; Fuhs, A; Hense, HW; Meister, A; Pauleikhoff, D; Schmidt, J; Wellmann, J | 1 |
| Amos, CI; Babaian, RJ; Chang, S; Clinton, SK; Contois, JH; Duphorne, CM; Erdman, JW; Gu, X; Hursting, SD; Scardino, PT; Spitz, MR; Strom, SS; Vadiveloo, M; Yamamura, Y | 1 |
| Dimitrov, P; Guymer, R; Hodge, A; McCarty, C; Robman, L; Tikellis, G; Vu, H | 1 |
| Jones, AA | 1 |
| Drake, T; Dwyer, JH; Dwyer, KM; Fogelman, AM; Hama-Levy, S; Hassan, K; Hough, G; Merz, CN; Navab, M; Shircore, A; Sun, P; Wang, X | 1 |
| Cherubini, A; Mecocci, P; Polidori, MC; Senin, U; Sies, H; Stahl, W | 1 |
6 review(s) available for lutein and Disease Exacerbation
| Article | Year |
|---|---|
Fatty Acids and Lipid Derivatives Protecting Photooxidative Attack in Age-related Macular Degeneration.
Topics: Carotenoids; Dietary Supplements; Disease Progression; Fatty Acids; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Nutrition Therapy; Protective Agents; Sedentary Behavior; Smoking; Vitamins | 2021 |
Long-term changes in optic coherence tomography in a child with laser pointer maculopathy: A case report and mini review.
Topics: Adolescent; Disease Progression; Eye Injuries; Humans; Lasers; Longitudinal Studies; Lutein; Male; Reproducibility of Results; Retina; Sensitivity and Specificity; Tomography, Optical Coherence; Treatment Outcome | 2017 |
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Topics: Aged; Antioxidants; Dietary Supplements; Disease Progression; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Minerals; Quality of Life; Randomized Controlled Trials as Topic; Vitamin E; Vitamins; Zeaxanthins; Zinc | 2017 |
Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
Topics: Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins; Zinc Compounds | 2014 |
Nutritional supplements in age-related macular degeneration.
Topics: Administration, Oral; Antioxidants; Ascorbic Acid; beta Carotene; Copper; Dietary Supplements; Disease Progression; Drug Combinations; Humans; Lutein; Macular Degeneration; Vision Disorders; Vitamin E; Vitamins; Zeaxanthins; Zinc | 2015 |
Age related macular degeneration--should your patients be taking additional supplements?
Topics: Age Factors; Antioxidants; Dietary Supplements; Disease Progression; Evidence-Based Medicine; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Risk Factors; Xanthophylls; Zeaxanthins | 2007 |
14 trial(s) available for lutein and Disease Exacerbation
| Article | Year |
|---|---|
Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-Related Macular Degeneration: AREDS2 Report 24.
Topics: Aged; Aged, 80 and over; Diagnostic Imaging; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Follow-Up Studies; Geographic Atrophy; Humans; Lutein; Macula Lutea; Male; Middle Aged; Prospective Studies; Treatment Outcome; Wet Macular Degeneration; Zeaxanthins | 2021 |
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Topics: Aged; Aged, 80 and over; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photography; Prospective Studies; Visual Acuity; Zeaxanthins | 2018 |
No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18
Topics: Aged; Aged, 80 and over; beta Carotene; Carotenoids; Complement Factor H; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Combinations; Fatty Acids, Omega-3; Female; Genetic Association Studies; Genome-Wide Association Study; Genotyping Techniques; Humans; Lutein; Macular Degeneration; Male; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proteins; Visual Acuity; Zeaxanthins; Zinc Compounds | 2019 |
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Topics: Aged; beta Carotene; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Double-Blind Method; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Incidence; Lung Neoplasms; Lutein; Macular Degeneration; Male; Middle Aged; Risk; Treatment Outcome; Vitamins; Xanthophylls; Zeaxanthins; Zinc | 2013 |
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aging; Cataract; Cataract Extraction; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Lutein; Male; Vision Disorders; Visual Acuity; Xanthophylls; Zeaxanthins | 2013 |
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
Topics: Administration, Oral; Aged; Aged, 80 and over; beta Carotene; Diet; Dietary Supplements; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Geographic Atrophy; Humans; Lutein; Male; Middle Aged; Retinal Drusen; Trace Elements; Treatment Outcome; Visual Acuity; Vitamins; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2014 |
Consuming a buttermilk drink containing lutein-enriched egg yolk daily for 1 year increased plasma lutein but did not affect serum lipid or lipoprotein concentrations in adults with early signs of age-related macular degeneration.
Topics: Aged; Beverages; Cardiovascular Diseases; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cultured Milk Products; Diet; Dietary Supplements; Disease Progression; Egg Yolk; Female; Humans; Intestinal Absorption; Lutein; Macular Degeneration; Male; Middle Aged; Phytosterols; Time Factors | 2014 |
The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Dietary Supplements; Disease Progression; Fatty Acids, Omega-3; Female; Follow-Up Studies; Geographic Atrophy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lutein; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Visual Acuity; Wet Macular Degeneration; Zeaxanthins | 2015 |
The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cataract; Cataract Extraction; Disease Progression; Fatty Acids, Omega-3; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lutein; Macular Degeneration; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Prospective Studies; United States; Zeaxanthins | 2016 |
Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
Topics: Administration, Oral; Adult; Aged; Calcium Channel Blockers; Disease Progression; Female; Follow-Up Studies; Humans; Lutein; Male; Middle Aged; Nifedipine; Pilot Projects; Prospective Studies; Retinitis Pigmentosa; Tocopherols; Vision Disorders; Visual Field Tests; Visual Fields; Young Adult | 2011 |
Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial.
Topics: Bronchopulmonary Dysplasia; Dietary Supplements; Disease Progression; Double-Blind Method; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Lutein; Male; Retinopathy of Prematurity; Xanthophylls; Zeaxanthins | 2013 |
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
Topics: Aged; Aged, 80 and over; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Epidemiologic Methods; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Research Design; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins | 2012 |
Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).
Topics: Aged; Antioxidants; Case-Control Studies; Contrast Sensitivity; Dietary Supplements; Disease Progression; Double-Blind Method; Female; Glare; Humans; Lutein; Macular Degeneration; Male; Minerals; Treatment Outcome; Visual Acuity; Vitamins | 2004 |
Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Diet; Dietary Fats; Disease Progression; Female; Follow-Up Studies; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Odds Ratio; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome; Xanthophylls; Zeaxanthins | 2007 |
10 other study(ies) available for lutein and Disease Exacerbation
| Article | Year |
|---|---|
[Pharmacological and physiotherapeutic methods of treating non-exudative age-related macular degeneration].
Topics: Disease Progression; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Retinal Drusen; Zeaxanthins | 2021 |
Macular telangiectasia--changes in macular pigment optical density during a 5-year follow-up.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Lutein; Macula Lutea; Male; Middle Aged; Optical Imaging; Retinal Pigments; Retinal Telangiectasis; Zeaxanthins | 2014 |
Lutein prevents cataract development and progression in diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Glutathione; Glutathione Peroxidase; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lutein; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar | 2009 |
How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?
Topics: Clinical Trials as Topic; Dietary Supplements; Disease Progression; Drug Therapy, Combination; Humans; Lutein; Retinitis Pigmentosa; Vision Disorders; Visual Acuity; Visual Fields; Vitamin A | 2010 |
Letter from the DSMC regarding a clinical trial of lutein in patients with retinitis pigmentosa.
Topics: Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Dietary Supplements; Disease Progression; Drug Therapy, Combination; Humans; Lutein; Retinitis Pigmentosa; Vision Disorders; Visual Acuity; Visual Fields; Vitamin A | 2011 |
Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Geographic Atrophy; Humans; Intraocular Pressure; Lutein; Male; Middle Aged; Photometry; Retinal Pigments; Visual Acuity; Wet Macular Degeneration; Xanthophylls; Zeaxanthins | 2011 |
Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).
Topics: Aged; Aged, 80 and over; Aging; beta Carotene; Biomarkers; Dietary Supplements; Disease Progression; Female; Follow-Up Studies; Humans; Lutein; Macula Lutea; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Stereoisomerism; Xanthophylls; Zeaxanthins | 2005 |
Relationship between plasma carotenoids and prostate cancer.
Topics: Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Chromatography, High Pressure Liquid; Cryptoxanthins; Disease Progression; Humans; Isomerism; Lutein; Lycopene; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Xanthophylls; Zeaxanthins | 2005 |
Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study.
Topics: Adult; Animals; Apolipoproteins E; Arteriosclerosis; beta Carotene; Carotid Arteries; Cell Movement; Cells, Cultured; Coculture Techniques; Cohort Studies; Culture Media, Conditioned; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Los Angeles; Lutein; Male; Mice; Mice, Knockout; Middle Aged; Monocytes; Muscle, Smooth, Vascular; Oxidation-Reduction; Risk Factors; Ultrasonography | 2001 |
Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome.
Topics: Aged; Ascorbic Acid; beta Carotene; Brain Ischemia; Carotenoids; Chromatography, High Pressure Liquid; Disease Progression; Female; Humans; Lipid Peroxidation; Lutein; Lycopene; Male; Malondialdehyde; Oxidative Stress; Stroke; Vitamin A; Vitamin E; Xanthophylls; Zeaxanthins | 2002 |